Bioavailable Serum Estradiol May Alter Radiation Risk of Postmenopausal Breast Cancer: a Nested Case-control Study

Overview

Journal Int J Radiat Biol

Specialty Radiology

Date 2018 Jan 9

PMID 29307255

Citations 5

Authors

Eric J Grant

John B Cologne

Gerald B Sharp

Hidetaka Eguchi

Richard G Stevens

Shizue Izumi

Young-Min Kim

Amy Berrington de Gonzalez

Waka Ohishi

Kei Nakachi

Affiliations

Soon will be listed here.

Abstract

Purpose: Ionizing radiation and high levels of circulating estradiol are known breast cancer carcinogens. We investigated the risk of first primary postmenopausal breast cancer in relation to the combined effects of whole-body ionizing radiation exposure and prediagnostic levels of postmenopausal sex hormones, particularly bioavailable estradiol (bE).

Materials And Methods: A nested case-control study of 57 incident breast cancer cases matched with 110 controls among atomic bomb survivors. Joint effects of breast radiation dose and circulating levels of sex hormones were assessed using binary regression and path analysis.

Results And Conclusion: Radiation exposure, higher levels of bE, testosterone and progesterone, and established reproductive risk factors were positively associated with postmenopausal breast cancer risk. A test for mediation of the effect of radiation via bE level suggested a small (14%) but significant mediation (p = 0.004). The estimated interaction between radiation and bE was large but not significant (interaction = 3.86; p = 0.32). There is accumulating evidence that ionizing radiation not only damages DNA but also alters other organ systems. While caution is needed, some portion of the radiation risk of postmenopausal breast cancer appeared to be mediated through bE levels, which may be evidence for cancer risks due to both direct and indirect effects of radiation.

Citing Articles

Simulated Galactic Cosmic Radiation Exposure-Induced Mammary Tumorigenesis in Mice Coincides with Activation of ERα-ERRα-SPP1 Signaling Axis.

Kumar K, Angdisen J, Ma J, Datta K, Fornace Jr A, Suman S Cancers (Basel). 2024; 16(23).

PMID: 39682141 PMC: 11640058. DOI: 10.3390/cancers16233954.

Dose-Response Effects of Low-Dose Ionizing Radiation on Blood Parameters in Industrial Irradiation Workers.

Guo J, Liu N, Ma Z, Gong Z, Liang Y, Cheng Q Dose Response. 2022; 20(2):15593258221105695.

PMID: 35693871 PMC: 9174562. DOI: 10.1177/15593258221105695.

Effects of exposure to low-dose ionizing radiation on changing platelets: a prospective cohort study.

Liu N, Peng Y, Zhong X, Ma Z, He S, Li Y Environ Health Prev Med. 2021; 26(1):14.

PMID: 33494698 PMC: 7836727. DOI: 10.1186/s12199-021-00939-z.

Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Helm J, Rudel R Arch Toxicol. 2020; 94(5):1511-1549.

PMID: 32399610 PMC: 7261741. DOI: 10.1007/s00204-020-02752-z.

Cost-Effective Extreme Case-Control Design Using a Resampling Method.

Kim Y, Im J Evol Bioinform Online. 2019; 15:1176934319838821.

PMID: 30992655 PMC: 6449816. DOI: 10.1177/1176934319838821.

References

Pedram A, Razandi M, Evinger A, Lee E, Levin E . Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell. 2009; 20(14):3374-89. PMC: 2710824. DOI: 10.1091/mbc.e09-01-0085. View

Hayashi T, Morishita Y, Kubo Y, Kusunoki Y, Hayashi I, Kasagi F . Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am J Med. 2005; 118(1):83-6. DOI: 10.1016/j.amjmed.2004.06.045. View

Lange T, Hansen J . Direct and indirect effects in a survival context. Epidemiology. 2011; 22(4):575-81. DOI: 10.1097/EDE.0b013e31821c680c. View

Hill D, Gilbert E, Dores G, Gospodarowicz M, van Leeuwen F, Holowaty E . Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood. 2005; 106(10):3358-65. PMC: 1895063. DOI: 10.1182/blood-2005-04-1535. View

Solleveld H, van Zwieten M, Broerse J, HOLLANDER C . Effects of X-irradiation, ovariohysterectomy and estradiol-17 beta on incidence, benign/malignant ratio and multiplicity of rat mammary neoplasms--a preliminary report. Leuk Res. 1986; 10(7):755-9. DOI: 10.1016/0145-2126(86)90292-4. View

Tokunaga M, Land C, Tokuoka S, Nishimori I, Soda M, Akiba S . Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res. 1994; 138(2):209-23. View

Cologne J, Sharp G, Neriishi K, Verkasalo P, Land C, Nakachi K . Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure. Int J Epidemiol. 2004; 33(3):485-92. DOI: 10.1093/ije/dyh097. View

Russo I, Russo J . Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia. 2011; 16(3):221-33. DOI: 10.1007/s10911-011-9228-y. View

Wong F, Yamada M, Sasaki H, Kodama K, Hosoda Y . Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res. 1999; 151(6):736-46. View

10.

Greenland S . Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med. 1983; 2(2):243-51. DOI: 10.1002/sim.4780020219. View

11.

Bezemer I, Rinaldi S, Dossus L, van Gils C, Peeters P, van Noord P . C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2005; 16(5):561-72. DOI: 10.1007/s10552-004-7472-9. View

12.

Ronckers C, Doody M, Lonstein J, Stovall M, Land C . Multiple diagnostic X-rays for spine deformities and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17(3):605-13. DOI: 10.1158/1055-9965.EPI-07-2628. View

13.

Pierce D, Stram D, Vaeth M . Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 1990; 123(3):275-84. View

14.

Preston D, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M . Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007; 168(1):1-64. DOI: 10.1667/RR0763.1. View

15.

Akahoshi M, Amasaki Y, Soda M, Hida A, Imaizumi M, Nakashima E . Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. Hypertens Res. 2004; 26(12):965-70. DOI: 10.1291/hypres.26.965. View

16.

Preston D, Krestinina L, Sokolnikov M, Ron E, Davis F, Ostroumova E . How much can we say about site-specific cancer radiation risks?. Radiat Res. 2010; 174(6):816-24. DOI: 10.1667/RR2024.1. View

17.

Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M . Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 2010; 340:b5349. PMC: 2806940. DOI: 10.1136/bmj.b5349. View

18.

Grant E, Neriishi K, Cologne J, Eguchi H, Hayashi T, Geyer S . Associations of ionizing radiation and breast cancer-related serum hormone and growth factor levels in cancer-free female A-bomb survivors. Radiat Res. 2011; 176(5):678-87. PMC: 3925891. DOI: 10.1667/rr2631.1. View

19.

Land C, Hayakawa N, Machado S, Yamada Y, Pike M, Akiba S . A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control. 1994; 5(2):167-76. DOI: 10.1007/BF01830263. View

20.

Brooks J, Boice Jr J, Stovall M, Reiner A, Bernstein L, John E . Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2012; 84(4):917-24. PMC: 3394928. DOI: 10.1016/j.ijrobp.2012.01.047. View